NQO1 and neurodegenerative disease: In neurodegenerative diseases like Alzheimer’s, benfotiamine activates the transcription factor Nrf2, leading to increased expression of genes encoding antioxidant enzymes such as heme oxygenase 1 (HO-1) and quinone reductase 1 (NQO1) [64].